Highly Potent Drugs

Aug 16, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
Aug 02, 2016
Pharmaceutical Technology
The design of Baxter BioPharma Solutions’ aseptic filling lines provides a case study in customizing containment systems for multi-product lines
Jul 26, 2016
By Pharmaceutical Technology Editors
The project involves installation of a small-scale pressured agitated nutsche filter dryer in glass, integrated in a high-containment isolator to achieve an occupational exposure limit of less than 1 microgram per meter cube, 8-hour time weighted average.
Jun 16, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Hovione expands drug substance and HPAPI capacity in East Windsor, New Jersey.
May 16, 2016
By Pharmaceutical Technology Editors
Combining powder micro-dosing services with the Xcelodose technology, Capsugel offers capabilities in both North America and Europe.
May 04, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
The production of antibody-drug conjugates requires biopharmaceutical and chemical manufacturing, and conjugation capabilities.
May 02, 2016
Pharmaceutical Technology
Safe handling of HPAPIs requires determining exposure potential and selecting appropriate containment strategies.
Apr 22, 2016
Highly potent or cytotoxic drugs require special handling
Apr 02, 2016
Pharmaceutical Technology
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
Mar 24, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
native1_300x100
lorem ipsum